Literature DB >> 8244456

Thrombin generates monocyte chemotactic activity from complement factor H.

H Ohtsuka1, T Imamura, M Matsushita, S Tanase, H Okada, M Ogawa, T Kambara.   

Abstract

We have recently found that the complement factor H (H) was the precursor of the major macrophage chemotactic factor in the delayed-type hypersensitivity (DTH) reaction site in the skin and was converted to the factor by an unidentified trypsin-like protease in plasma. Thrombin and plasmin are also present in the site, and we, therefore, examined the possibility that these proteases converted H to be monocyte chemotactic. Intact H caused no monocyte migration, although it was able to do so after incubation with thrombin, but not with plasmin. The activity was chemotactic rather than chemokinetic and was absorbed by an anti-H IgG-conjugated column. The generation of monocyte chemotactic activity from H was dependent on incubation time with thrombin and also the protease activity of thrombin, and the activity was seen at concentrations of H lower than 10(-8) M. The inhibitory activity of H for C3b-Bb was not affected by incubation with thrombin or plasmin. Incubation of H with thrombin, but not with plasmin, generated a hydrophobic molecule, in a time-dependent manner, which had monocyte chemotactic activity. These results show that H becomes a monocyte chemotactic factor due to cleavage by thrombin, which converts H to a more hydrophobic molecule and also suggest that thrombin-treated H induces monocyte migration in the DTH reaction site.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244456      PMCID: PMC1422117     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions.

Authors:  R B Colvin; H F Dvorak
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  Prothrombin.

Authors:  K G Mann
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

3.  The chemotactic activity of native and denatured serum albumin.

Authors:  P C Wilkinson; I C McKay
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

4.  The effects of anticoagulants and other drugs on cellular and cutaneous reactions to antigen in guinea-pigs with delayed-type hypersensitivity.

Authors:  D S Nelson
Journal:  Immunology       Date:  1965-09       Impact factor: 7.397

5.  A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration.

Authors:  W Falk; R H Goodwin; E J Leonard
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

7.  A new biological activity of the complement factor H: identification of the precursor of the major macrophage-chemotactic factor in delayed hypersensitivity reaction sites of guinea pigs.

Authors:  T Imamura; H Ohtsuka; M Matsushita; J Tsuruta; H Okada; T Kambara
Journal:  Biochem Biophys Res Commun       Date:  1992-06-15       Impact factor: 3.575

8.  Control of the amplification convertase of complement by the plasma protein beta1H.

Authors:  J M Weiler; M R Daha; K F Austen; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

9.  Modulation of the alternative complement pathways by beta 1 H globulin.

Authors:  K Whaley; S Ruddy
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man.

Authors:  R B Colvin; R A Johnson; M C Mihm; H F Dvorak
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  8 in total

1.  The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein.

Authors:  M Oppermann; T Manuelian; M Józsi; E Brandt; T S Jokiranta; S Heinen; S Meri; C Skerka; O Götze; P F Zipfel
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Identification of human complement factor H as a chemotactic protein for monocytes.

Authors:  K Nabil; B Rihn; M C Jaurand; J M Vignaud; J Ripoche; Y Martinet; N Martinet
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  The human complement regulatory factor-H-like protein 1, which represents a truncated form of factor H, displays cell-attachment activity.

Authors:  J Hellwage; S Kühn; P F Zipfel
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

Review 4.  Self-Damage Caused by Dysregulation of the Complement Alternative Pathway: Relevance of the Factor H Protein Family.

Authors:  Pilar Sánchez-Corral; Richard B Pouw; Margarita López-Trascasa; Mihály Józsi
Journal:  Front Immunol       Date:  2018-07-12       Impact factor: 7.561

5.  Complement Factor H Family Proteins Modulate Monocyte and Neutrophil Granulocyte Functions.

Authors:  Éva Kárpáti; Mariann Kremlitzka; Noémi Sándor; Dávid Hajnal; Andrea E Schneider; Mihály Józsi
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561

6.  Factor h: a complement regulator in health and disease, and a mediator of cellular interactions.

Authors:  Anne Kopp; Mario Hebecker; Eliška Svobodová; Mihály Józsi
Journal:  Biomolecules       Date:  2012-02-07

Review 7.  Complement factor H in host defense and immune evasion.

Authors:  Raffaella Parente; Simon J Clark; Antonio Inforzato; Anthony J Day
Journal:  Cell Mol Life Sci       Date:  2016-12-10       Impact factor: 9.261

8.  Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages.

Authors:  Karolina I Smolag; Christine M Mueni; Karin Leandersson; Karin Jirström; Catharina Hagerling; Matthias Mörgelin; Paul N Barlow; Myriam Martin; Anna M Blom
Journal:  Oncoimmunology       Date:  2020-03-06       Impact factor: 8.110

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.